ErbB4 is overexpressed in a variety of epithelial tissue-derived malignancies, such as lung cancer, ovarian cancer, prostate cancer, bladder cancer, and cervical cancer, which suggests that the change of ErbB4 expression is closely related to the occurrence and evolution of tumors. Here, ERBB4 is linked to prostate cancer.